5.96
price up icon8.86%   0.485
after-market Dopo l'orario di chiusura: 6.10 0.14 +2.35%
loading

Kala Bio Inc Borsa (KALA) Ultime notizie

pulisher
Jul 15, 2025

What makes KALA BIO Inc. stock price move sharplyTop Performing Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why KALA BIO Inc. stock attracts strong analyst attentionMomentum Buy Alert - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How KALA BIO Inc. stock performs during market volatilityFree Wealth-Building Investment Strategies - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

All Eyes On KALA's CHASEWill The PCED Trial Make Its Case? - RTTNews

Jul 14, 2025
pulisher
Jul 13, 2025

LADENBURG THALM/SH SH Initiates Coverage on KALA BIO (NASDAQ:KALA) - Defense World

Jul 13, 2025
pulisher
Jul 12, 2025

KALA Bio completes enrollment of CHASE clinical trial - Ophthalmology Times

Jul 12, 2025
pulisher
Jul 12, 2025

KALA BIO (NASDAQ:KALA) Upgraded by Wall Street Zen to Hold Rating - Defense World

Jul 12, 2025
pulisher
Jul 11, 2025

This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga

Jul 11, 2025
pulisher
Jul 09, 2025

Kala Bio Announces Completion of Enrollment in Chase Clinical Trial Evaluating Kpi-012 for the Treatment of Persistent Corneal Epithelial Defect - MarketScreener

Jul 09, 2025
pulisher
Jul 09, 2025

KALA Completes Patient Enrollment in Phase 2b CHASE Trial for KP - GuruFocus

Jul 09, 2025
pulisher
Jul 09, 2025

Kala Pharmaceuticals Completes Enrollment for Phase 2b Trial - TipRanks

Jul 09, 2025
pulisher
Jul 09, 2025

Kala Bio completes enrollment in Phase 2b trial for KPI-012 in eye disorder - Investing.com

Jul 09, 2025
pulisher
Jul 09, 2025

KALA BIO Completes Patient Enrollment in CHASE Phase 2b Trial for KPI-012, Anticipates Topline Results by Q3 2025 - Quiver Quantitative

Jul 09, 2025
pulisher
Jul 09, 2025

KALA BIO Announces Completion of Enrollment in CHASE - GlobeNewswire

Jul 09, 2025
pulisher
Jul 09, 2025

KALA BIO Eyes 100,000 Patient Market as Pivotal PCED Trial Completes Enrollment, Q3 Results Ahead - Stock Titan

Jul 09, 2025
pulisher
Jul 07, 2025

KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discu - GuruFocus

Jul 07, 2025
pulisher
Jul 07, 2025

KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to - GlobeNewswire

Jul 07, 2025
pulisher
Jul 07, 2025

KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED) - Yahoo Finance

Jul 07, 2025
pulisher
Jun 06, 2025

Millennium Management LLC Purchases 17,130 Shares of HBT Financial, Inc. (NASDAQ:HBT) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Millennium Management LLC Decreases Stake in KALA BIO, Inc. (NASDAQ:KALA) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Nexa Resources S.A. (NYSE:NEXA) Shares Sold by Millennium Management LLC - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

24,353 Shares in T. Rowe Price Floating Rate ETF (NYSEARCA:TFLR) Acquired by Bank of America Corp DE - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Cadre Holdings, Inc. (NYSE:CDRE) Shares Acquired by Millennium Management LLC - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Bank of America Corp DE Acquires 2,612 Shares of First Trust Indxx Global Natural Resources Income ETF (NASDAQ:FTRI) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Millennium Management LLC Sells 1,791 Shares of Bluerock Homes Trust, Inc. (NYSEAMERICAN:BHM) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Ameriprise Financial Inc. Buys 11,012 Shares of Liberty All-Star Growth Fund, Inc. (NYSE:ASG) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Kala Bio director Mark Iwicki sells $40,638 in stock By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

Kala Bio director Mark Iwicki sells $40,638 in stock - Investing.com India

Jun 05, 2025
pulisher
Jun 04, 2025

KALA BIO Executives Sell Shares - TradingView

Jun 04, 2025
pulisher
Jun 04, 2025

Pre-market Movers: STSS, SGMT, NIVF, OGEN... - RTTNews

Jun 04, 2025
pulisher
Jun 03, 2025

KALA BIO (NASDAQ:KALA) Given “Outperform” Rating at Oppenheimer - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

KALA: Oppenheimer Announces Outperform Rating for Kala Bio | KALA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

KALA Stock Gains Momentum with Oppenheimer's Positive Outlook | - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

KALA Stock Gains Momentum with Oppenheimer's Positive Outlook | KALA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 01, 2025

Tidal Investments LLC Has $269,000 Stake in Air Lease Co. (NYSE:AL) - Defense World

Jun 01, 2025
pulisher
Jun 01, 2025

Aegon Ltd. (NYSE:AEG) Shares Sold by Millennium Management LLC - Defense World

Jun 01, 2025
pulisher
May 29, 2025

KALA BIO to Present at Jefferies Global Healthcare Conference - The Manila Times

May 29, 2025
pulisher
May 29, 2025

KALA BIO to Reveal Latest Eye Disease Pipeline Progress at Major Jefferies Healthcare Conference - Stock Titan

May 29, 2025
pulisher
May 26, 2025

Q1 Earnings Estimate for KALA BIO Issued By HC Wainwright - Defense World

May 26, 2025
pulisher
May 25, 2025

HC Wainwright Lowers KALA BIO (NASDAQ:KALA) Price Target to $12.00 - Defense World

May 25, 2025
pulisher
May 24, 2025

Kala Bio stock target cut to $12 by H.C. Wainwright, retains buy - Investing.com Nigeria

May 24, 2025
pulisher
May 23, 2025

KALA Stock: HC Wainwright & Co. Adjusts Price Target for Kala Bi - GuruFocus

May 23, 2025
pulisher
May 23, 2025

KALA Stock: HC Wainwright & Co. Adjusts Price Target for Kala Bio | KALA Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

KALA Price Target Reduced by H.C. Wainwright After Q3 Results | - GuruFocus

May 23, 2025
pulisher
May 23, 2025

KALA Price Target Reduced by H.C. Wainwright After Q3 Results | KALA Stock News - GuruFocus

May 23, 2025
pulisher
May 15, 2025

KALA BIO: Q1 Earnings Snapshot - New Haven Register

May 15, 2025
pulisher
May 14, 2025

Persistent Epithelial Defect Market on Track for Major - openPR.com

May 14, 2025
pulisher
May 14, 2025

KALA Focuses on Advancing KPI-012 Development Amid Pivotal Trials | KALA Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Kala Pharmaceuticals reports Q1 EPS ($1.41) vs ($4.20) last year - TipRanks

May 14, 2025
$21.87
price up icon 3.40%
$35.60
price down icon 2.49%
$104.59
price up icon 1.67%
$28.27
price up icon 16.05%
$112.49
price up icon 1.66%
biotechnology ONC
$279.16
price up icon 3.51%
Capitalizzazione:     |  Volume (24 ore):